Try our Advanced Search for more refined results
February 13, 2017
IN RE GALENA BIOPHARMA, INC. SECURITIES LITIGATION
Case Number:
2:17-cv-00929
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Carella Byrne
- Faruqi & Faruqi
- Goodwin Procter
- Greenberg Traurig
- Hughes Hubbard
- Kantrowitz Goldhamer
- McCune Wright
- Paul Hastings
- Riley Safer
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 16, 2021
Galena Settles Investors' Revived Opioid Row For $1.6M
A group of investors has urged a New Jersey federal judge to grant preliminary approval to a $1.6 million settlement with Galena Biopharma Inc. to resolve allegations the company caused a stock drop with purported misrepresentations regarding its fentanyl-based drug Abstral.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login